Risk of rheumatic-fever recurrences after streptococcal infections. Prospective study of clinical and social factors.
D000284:Administration, Oral; D000293:Adolescent; D001741:Black or African American; D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D000989:Antistreptolysin / Q000032:analysis; D006332:Cardiomegaly / Q000150:complications; D002648:Child; D005006:Ethnicity; D006801:Humans; D007182:Income; D007273:Injections, Intramuscular; D010401:Penicillin G Benzathine / Q000008:administration & dosage; D010406:Penicillins / Q000008:administration & dosage; D010612:Pharyngitis / Q000150:complications; D011446:Prospective Studies; D012008:Recurrence; D012213:Rheumatic Fever / Q000209:etiology / Q000235:genetics / Q000517:prevention & control; D012214:Rheumatic Heart Disease / Q000150:complications; D012959:Socioeconomic Factors; D013290:Streptococcal Infections / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D013297:Streptococcus pyogenes / Q000276:immunology; D013411:Sulfadiazine / Q000008:administration & dosage; D013997:Time Factors; D044465:White People
D000906:Antibodies; D010406:Penicillins; D013411:Sulfadiazine; D000989:Antistreptolysin; D010401:Penicillin G Benzathine